泰安市中心医院食管胃肠肿瘤内科举办肿瘤多学科诊疗(MDT)前沿研讨会,共探肺癌综合治疗新进展
Qi Lu Wan Bao·2025-12-01 07:25

Core Insights - The recent MDT academic conference focused on "New Advances in Chest Tumor Treatment and Clinical Practice," highlighting the importance of multidisciplinary collaboration in cancer diagnosis and treatment [1][2] Group 1: Conference Overview - The conference was co-hosted by Shandong Provincial Cancer Hospital, PLA 960 Hospital, and Tai'an Central Hospital, attracting experts from various medical institutions in the Tai'an region [1] - Keynote speakers emphasized the significance of the MDT model in enhancing patient quality of life and promoting personalized treatment [1] Group 2: Professional Frontiers - Professor Meng Xue presented on "New Forces in Chest Radiotherapy," discussing advancements in proton therapy, radiotherapy combined with immunotherapy, and FLASH radiotherapy [1] - Professor Han Shumei provided an in-depth interpretation of the "2025 NCCN Anti-Nausea Clinical Practice Guidelines," focusing on updates regarding high-emetic-risk drugs and optimization of anti-nausea protocols [1] Group 3: Clinical Case Discussions - Professor He Chengxiang shared clinical cases on "CT-guided Lung Cancer Cryoablation," demonstrating the efficacy of cryoablation technology in early-stage lung cancer and non-surgical candidates [2] - Professor Wan Long discussed a complex case of advanced lung adenocarcinoma with esophageal metastasis, exploring treatment strategies post-EGFR-TKI resistance and the practical application of Ivoris monoclonal antibody [2] - MDT teams from both PLA 960 Hospital and Shandong Provincial Cancer Hospital presented various typical cases, showcasing the advantages of multidisciplinary thinking [2] Group 4: Overall Impact - The conference covered a wide range of topics including radiotherapy, anti-nausea medication, minimally invasive interventions, and immunotherapy strategies, reflecting a patient-centered approach to individualized treatment [2] - The event served as a high-quality academic exchange platform for the oncology community in Tai'an, promoting the enhancement of multidisciplinary collaboration and overall treatment standards in the region [2]